Your browser doesn't support javascript.
loading
The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian, David Z; Wang, Xiaofei; Kachhap, Sushant K; Kato, Yukihiko; Wei, Yongfeng; Zhang, Lu; Atadja, Peter; Pili, Roberto.
Affiliation
  • Qian DZ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland 21231, USA.
Cancer Res ; 64(18): 6626-34, 2004 Sep 15.
Article in En | MEDLINE | ID: mdl-15374977
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Pyridines / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / Histone Deacetylase Inhibitors / Hydroxamic Acids Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2004 Document type: Article
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Phthalazines / Pyridines / Antineoplastic Combined Chemotherapy Protocols / Angiogenesis Inhibitors / Vascular Endothelial Growth Factor Receptor-2 / Histone Deacetylase Inhibitors / Hydroxamic Acids Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2004 Document type: Article